跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,103 条关于
“PMGC Holdings”
全部
1,103
临床试验
116
药物
97
机构
152
资讯
738
去年
Northstrive Biosciences Advances AI-Powered Drug Discovery for Obesity and Cardiac Diseases
9个月前
NorthStrive Biosciences Advances AI-Driven Drug Discovery to Phase III for Muscle Preservation in Obesity Treatment
7个月前
NorthStrive Biosciences Advances EL-32 Manufacturing for Muscle Preservation in GLP-1 Therapy Patients
去年
Northstrive Biosciences Launches Preclinical Study of EL-32 Probiotic Combined with Semaglutide for Obesity Treatment
去年
Sareum's SDC-1801 Advances to Phase II Trials for Psoriasis Following Positive Phase I Results
去年
European Commission Approves Novo Holdings' $16.5B Catalent Acquisition
2年前
Bio-Path Holdings' BP1003 Demonstrates Therapeutic Potential in Diverse Cancers
2年前
Immunocore and Bristol Myers Squibb Collaborate on Phase 3 Trial for Advanced Cutaneous Melanoma
去年
ALX Oncology's Evorpacept Shows Promise in Multiple Cancer Trials
去年
CERO Therapeutics' CER-1236 Receives FDA Clearance for Clinical Trials
第 1 页,共 74 页
上一页
下一页